| Title |
Distinct human circulating NKp30+FcεRIγ+CD8+ T cell population exhibiting high natural killer-like antitumor potential
|
|---|---|
| Published in |
Proceedings of the National Academy of Sciences of the United States of America, June 2018
|
| DOI | 10.1073/pnas.1720564115 |
| Pubmed ID | |
| Authors | |
| Abstract |
CD8+ T cells are considered prototypical cells of adaptive immunity. Here, we uncovered a distinct CD8+ T cell population expressing the activating natural killer (NK) receptor NKp30 in the peripheral blood of healthy individuals. We revealed that IL-15 could de novo induce NKp30 expression in a population of CD8+ T cells and drive their differentiation toward a broad innate transcriptional landscape. The adaptor FcεRIγ was concomitantly induced and was shown to be crucial to enable NKp30 cell-surface expression and function in CD8+ T cells. FcεRIγ de novo expression required promoter demethylation and was accompanied by acquisition of the signaling molecule Syk and the "innate" transcription factor PLZF. IL-15-induced NKp30+CD8+ T cells exhibited high NK-like antitumor activity in vitro and were able to synergize with T cell receptor signaling. Importantly, this population potently controlled tumor growth in a preclinical xenograft mouse model. Our study, while blurring the borders between innate and adaptive immunity, reveals a unique NKp30+FcεRIγ+CD8+ T cell population with high antitumor therapeutic potential. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 35% |
| Italy | 1 | 5% |
| Germany | 1 | 5% |
| Sweden | 1 | 5% |
| Unknown | 10 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 80% |
| Scientists | 2 | 10% |
| Practitioners (doctors, other healthcare professionals) | 1 | 5% |
| Unknown | 1 | 5% |
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 79 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 24 | 30% |
| Researcher | 14 | 18% |
| Student > Bachelor | 6 | 8% |
| Student > Master | 4 | 5% |
| Other | 3 | 4% |
| Other | 6 | 8% |
| Unknown | 22 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 15 | 19% |
| Biochemistry, Genetics and Molecular Biology | 14 | 18% |
| Medicine and Dentistry | 9 | 11% |
| Agricultural and Biological Sciences | 7 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Other | 6 | 8% |
| Unknown | 26 | 33% |